These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6254355

  • 1. Plasma adrenocorticotrophic hormone in congenital adrenal hyperplasia. Importance in long-term management.
    LaFranchi S.
    Am J Dis Child; 1980 Nov; 134(11):1068-72. PubMed ID: 6254355
    [Abstract] [Full Text] [Related]

  • 2. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B, Roux H, Audi-Parera L, David M, Bertrand J.
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract] [Full Text] [Related]

  • 3. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography.
    Petersen KE, Christensen T.
    Acta Paediatr Scand; 1979 Mar; 68(2):205-11. PubMed ID: 217232
    [Abstract] [Full Text] [Related]

  • 4. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC, Elias LL.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [Abstract] [Full Text] [Related]

  • 5. Congenital adrenal hyperplasia family studies using the short ACTH test.
    Kreutzmann DJ, Cowell CT, Howard NJ, De Souza M, Silink M.
    Aust Paediatr J; 1989 Dec; 25(6):340-5. PubMed ID: 2619637
    [Abstract] [Full Text] [Related]

  • 6. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Dec; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 7. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.
    Barnes ND, Atherden SM.
    Arch Dis Child; 1972 Feb; 47(251):62-5. PubMed ID: 4336233
    [Abstract] [Full Text] [Related]

  • 9. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee PA, Rosenwaks Z, Urban MD, Migeon CJ, Bias WD.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
    [Abstract] [Full Text] [Related]

  • 10. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J.
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
    [Abstract] [Full Text] [Related]

  • 11. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
    Lippe BM, LaFranchi SH, Lavin N, Parlow A, Coyotupa J, Kaplan SA.
    J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
    [No Abstract] [Full Text] [Related]

  • 12. Plasma renin activity in the management of congenital adrenal hyperplasia.
    Griffiths KD, Anderson JM, Rudd BT, Virdi NK, Holder G, Rayner PH.
    Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
    [Abstract] [Full Text] [Related]

  • 13. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Bey-Omar F, Feit JP, Forest MG, David M.
    Pediatrie; 1983 Mar; 38(2):77-86. PubMed ID: 6622141
    [Abstract] [Full Text] [Related]

  • 14. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 15. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT, Raux MC, Gourmelen M, Baron MC, Girard F.
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA, Lippe BM, Kaplan SA, Lavin N, Mayes DM.
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.